Underling some of their key demands from the upcoming budget, Industry body for Pharma MSMEs has pointed out that provisions like Reverse Charging Mechanism and Input Tax Credit has created an inverted duty structure, making the companies to pay more, barring them to access their refunded money and have added an avoidable step in foreign trade. Read more: https://pharma.economictimes.indiatimes.com/news/pharma-industry/small-drug-manufacturers-calls-for-tweaking-reverse-charging-mechanism-and-input-tax-credit-in-budget-2025/117796284